Pacer Advisors, Inc. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pacer Advisors, Inc. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$2,315,745
+1.3%
313,362
+35.5%
0.01%
-25.0%
Q3 2022$2,285,000
-18.0%
231,296
-9.6%
0.02%
-23.8%
Q2 2022$2,788,000
+15.3%
255,774
+19.6%
0.02%
+5.0%
Q1 2022$2,418,000
+45.2%
213,787
+101.5%
0.02%
+17.6%
Q4 2021$1,665,000
+37.6%
106,123
+50.3%
0.02%
+13.3%
Q3 2021$1,210,000
-1.2%
70,612
+24.0%
0.02%
-16.7%
Q2 2021$1,225,000
+146.0%
56,935
+71.9%
0.02%
+100.0%
Q1 2021$498,000
+219.2%
33,123
+178.7%
0.01%
+200.0%
Q4 2020$156,000
+50.0%
11,884
+9.9%
0.00%
+50.0%
Q3 2020$104,000
+76.3%
10,817
+109.0%
0.00%
+100.0%
Q2 2020$59,000
-1.7%
5,176
-1.1%
0.00%0.0%
Q1 2020$60,000
-65.9%
5,236
-51.0%
0.00%
-87.5%
Q4 2019$176,000
-17.8%
10,696
-33.7%
0.01%
+60.0%
Q3 2019$214,000
+55.1%
16,125
+64.4%
0.01%
+66.7%
Q2 2019$138,000
+56.8%
9,809
+156.6%
0.00%0.0%
Q3 2018$88,000
+417.6%
3,823
+239.8%
0.00%
+200.0%
Q4 2017$17,0001,1250.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders